Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Jincheng Wang, Kaili Hu, Xuanyan Cai, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 18-32
Open Access | Times Cited: 249

Showing 1-25 of 249 citing articles:

Macrophage Polarization and the Regulation of Bone Immunity in Bone Homeostasis
Kangyi Hu, Zhengya Shang, Xiaorui Yang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3563-3580
Open Access | Times Cited: 51
Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice
Lin Pan, Yiju Cheng, Wenting Yang, et al.
Inflammation (2023) Vol. 46, Iss. 4, pp. 1531-1542
Open Access | Times Cited: 48
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Ningning Guo, Xin Wang, Muran Xu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107300-107300
Open Access | Times Cited: 23
Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 2
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Martina Korfei, Poornima Mahavadi, Andreas Guenther
Cells (2022) Vol. 11, Iss. 10, pp. 1626-1626
Open Access | Times Cited: 45
Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis
Huamin Zhang, Yutong Zhou, Dada Wen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1801-1801
Open Access | Times Cited: 25
Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway
Wei Zhang, Pinfang Kang, Jing Zhou, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 24
Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation
Yi Liao, Yan Yang, Guanghong Zhou, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 6, pp. 679-693
Closed Access | Times Cited: 10
Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Chitooligosaccharides promote diabetic wound healing by mediating fibroblast proliferation and migration
Zihan Li, Chuwei Zhang, Lei Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Phillygenin Inhibits PI3K‐Akt–mTOR Signalling Pathway to Prevent bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice
Yongjia Wei, Wenting Ni, Lizhi Zhao, et al.
Clinical and Experimental Pharmacology and Physiology (2025) Vol. 52, Iss. 2
Closed Access | Times Cited: 1
Evolution of BHA modification strategy：Anti-inflammation approach rescues the Calcium-NLR-inflammation axis mediated periodontal redevelopment failure
Xuan Zhou, Junlong Xue, Yanshu Zhang, et al.
Biomaterials Research (2025) Vol. 29
Open Access | Times Cited: 1
Topical transdermal administration of lenalidomide nanosuspensions-based hydrogels against melanoma: In vitro and in vivo studies
Meng‐Di Zhang, Haiying Qiu, Zheyi Han, et al.
International Journal of Pharmaceutics X (2025) Vol. 9, pp. 100316-100316
Closed Access | Times Cited: 1
Targeting the cholinergic anti-inflammatory pathway: an innovative strategy for treating diseases
Yifan Li, Shufan Ding, Yongjie Wang
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
DRD2‐Mediated AMPK Ubiquitination Regulates the Occurrence of Hepatic Steatosis
Peng Ma, Hao Ou, Jianan Cai, et al.
Liver International (2025) Vol. 45, Iss. 4
Closed Access | Times Cited: 1
Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation
Zhesong Deng, Jinkun Chen, Ruonan Yang, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Signaling pathways involved in paraquat-induced pulmonary toxicity: Molecular mechanisms and potential therapeutic drugs
Xianbo Liu, He Yang, Zhenning Liu
International Immunopharmacology (2022) Vol. 113, pp. 109301-109301
Closed Access | Times Cited: 33
Suppressing NLRP3 activation and PI3K/AKT/mTOR signaling ameliorates amiodarone-induced pulmonary fibrosis in rats: a possible protective role of nobiletin
Manar Mohammed El Tabaa, Maram Mohammed El Tabaa, Rehab M. Elgharabawy, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1373-1386
Closed Access | Times Cited: 21
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
Hehua Guo, Jiazheng Sun, Siyu Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)
Shan Han, Qiangwei Lu, Xiaoqiu Liu
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 17
Multi-omics analysis reveals overactive inflammation and dysregulated metabolism in severe community-acquired pneumonia patients
Jieqiong Li, Yawen Wang, Weichao Zhao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy
Jianying Qi, Yuanyuan Wu, Zhimou Guo, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132896-132896
Closed Access | Times Cited: 8
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis
Jie Tan, Qianfei Xue, Xiao Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads
Yuejiao Wang, Xue Wang, Chaoqi Du, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Nintedanib Mitigates Radiation-Induced Pulmonary Fibrosis by Suppressing Epithelial Cell Inflammatory Response and Inhibiting Fibroblast-to-Myofibroblast Transition
Jingyao Tu, Xinyi Chen, Chunya Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3353-3371
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top